Skip to main content

Data

Design and Pilot Engagement Programs

Work with the Cross Optum team and take advantage of our connections to all parts of the health system.

Cross Optum programs turn evidence into action

In this fragmented healthcare landscape, life sciences organizations are faced with the challenge of how to connect the pieces. They’re asking how to:

  • Improve efficiency of timely diagnosis
  • Test new processes that could improve clinical decision-making and therapy adherence
  • Discover effective ways to improve guidelines for directed therapy and evidence-based medicine
  • Understand patient and provider behavior in the real world
  • Educate patients on therapy options and the benefits of staying on track with their treatment

Small changes can make a big difference. The Cross Optum team works with life sciences companies and the larger UnitedHealth Group® enterprise to identify unmet needs, design and pilot engagement programs, and evaluate outcomes.

Connecting parts of the healthcare ecosystem

Our team uses implementation science to generate evidence that serves as a catalyst to improve the future of health care.

Key benefits

Clinical programs and process improvements to existing interactions help foster adoption across stakeholders. We focus on the following:  

Disease awareness and prevention

Identify at-risk individuals and help resolve healthcare gaps.

Guideline-directed care

Improve quality and consistency of patient care across the healthcare ecosystem. 

Treatment, intensification and adherence

Collaborate to increase adherence and improve outcomes.

Case study

Lowering cardiovascular disease risk

An innovative program involving patient awareness and provider outreach helps improve patient use of lipid-lowering therapies.  

Build evidence to reach and treat the right populations

Optum designed a program to introduce an assessment tool and prepare clinicians with training and a guide to aid diagnosis and treatment.

Related healthcare insights

Article

Lowering cardiovascular disease risk

An innovative program involving patient awareness and provider outreach improves patient use of lipid-lowering therapies.

Article

Using epidemiological data build public confidence

See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.

Guide

Informing FDA best initiative

As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.

Olivia Banyon, MPH
Vice President

Tina Kelley
Senior Director

Aimee Coughlin, MBA
Senior Consultant

Katherine Ferro, MHSA, MBA
Senior Consultant

Nick Payne, MBA
Senior Consultant

Kizzy Steward-Judie, PharmD, MBA
Clinical Lead Consultant

Maggie Reyes-Leczinski
Senior Consultant

Sheriden Beard, MPH
Senior Research Analyst

 

See how our real-world data can benefit your business